Global Life Science Company
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines FDA regulatory issues
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
Re-authorization of the Pandemic and All-Hazards Preparedness Act
NDAA - provisions related to biological and chemical defense
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations
provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
NDAA - provisions related to biological and chemical defense
Issues related to Priority Review Voucher programs
Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines NDAA - provisions related to biological and chemical defense
Department of Defense appropriations for Medical Countermeasures
DIS - Disaster Planning/Emergencies HCR - Health Issues BUD - Budget/Appropriations HOM - Homeland Security DEF - Defense
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
DOTCHIN & ASSOCIATES, LLC
412 North Saint Asaph Street, Alexandria, VA, 22314, US
ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN ROBERT J. DOTCHIN